Pharmaceutical companies that increase their prices above inflation in the US will be fined

In the statement made by the Center for Medicare and Medicaid Services (CMS), it was reported that the US Department of Health and Human Services published guidance on how to impose penalties on pharmaceutical companies that increase prices faster than inflation under the “Inflation Reduction Law”. “.

US Health and Human Services Secretary Xavier Becerra, whose views were included in the statement, stressed that there is no reason for Americans to pay 2-3 times as much for the same drugs as in other countries, and that the government is determined to reduce the cost of health services Pharmaceutical companies that increase their prices faster than the rate of inflation will have to pay the Medicare Trust Fund, “he used the phrase.

In the statement, which also includes important dates in this context, it was noted that the first 3-month period began on January 1 in which pharmaceutical companies must reimburse prices that exceed inflation on certain drugs.

In the statement, it was reported that CMS plans to send its first invoices to pharmaceutical companies for reimbursement in 2025.

Consequently, pharmaceutical companies will have to limit their annual price increases to the rate of inflation. Starting in 2025, the national health insurance program, Medicare, will bill companies that raise prices to a higher rate for the difference. Manufacturers of pharmaceutical products that do not make the payment will be penalized with a fine of 125 percent of the amount. (AA)